Company Filing History:
Years Active: 2023
Title: Innovations in Avian Influenza Treatment by Meilin Jin
Introduction
Meilin Jin is a notable inventor based in Hubei, China, recognized for her contributions to the field of medicine, particularly in the treatment and prevention of avian influenza virus infections. With a total of two patents, her work has significant implications for animal health and disease management.
Latest Patents
Meilin Jin's latest patents focus on the application of compound bacterium preparations for treating or preventing avian influenza virus infections. One of her inventions reveals that ATCC Accession No. 25527 can effectively treat animals infected by the H7N9 strain. When compounded with ATCC Accession No. 25526, the therapeutic effect is enhanced. This compound preparation not only regulates the immune response but also significantly improves weight loss and lung tissue injury caused by H7N9 infections, leading to a higher survival rate in infected mice. Additionally, her work on the application of valine in medicine preparation demonstrates its effectiveness in improving the health outcomes of infected mice, reducing weight loss, increasing survival rates, and lowering virus titers in lung tissue.
Career Highlights
Meilin Jin is affiliated with Huazhong Agricultural University, where she conducts her research and develops innovative solutions for combating avian influenza. Her dedication to advancing medical science is evident through her impactful inventions.
Collaborations
Meilin collaborates with esteemed colleagues, including Qiang Zhang and Xiaotong Hu, to further enhance her research and its applications in veterinary medicine.
Conclusion
Meilin Jin's innovative work in the field of avian influenza treatment showcases her commitment to improving animal health through scientific research and invention. Her contributions are vital in the ongoing battle against viral infections in livestock.